A Study of Pain Relief in Low Back Pain
NCT00325949 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 770
Last updated 2011-07-25
Summary
This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain
Conditions
- Chronic Low Back Pain
Interventions
- DRUG
-
Extended release hydrocodone and acetaminophen (Vicodin CR)
2 tablets BID
- DRUG
-
hydrocodone/acetaminophen extended release (Vicodin CR)
1 tablet BID
- DRUG
-
2 tablets BID
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Rita Jain, M.D. · Abbott
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2007-05-31
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
NCT01081912 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
NCT01789970 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
NCT01922739 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
NCT00986258 ·Status: TERMINATED ·Phase: PHASE3
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)
NCT01685684 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
NCT02716857 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
NCT03201393 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
NCT01240863 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
NCT00983385 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
NCT01838616 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain
NCT01115569 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
NCT03137030 ·Status: WITHDRAWN ·Phase: PHASE1
-
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
NCT00771758 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
NCT03137017 ·Status: WITHDRAWN ·Phase: PHASE1
-
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
NCT01400139 ·Status: COMPLETED ·Phase: PHASE3
-
Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users
NCT01759446 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
NCT01631513 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain
NCT00594516 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen
NCT03567941 ·Status: COMPLETED ·Phase: PHASE1
-
Evolution of Analgesic Tolerance With Opioids
NCT00275249 ·Status: COMPLETED ·Phase: NA
-
Opioid Taper Study
NCT03912298 ·Status: COMPLETED
-
Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back Pain
NCT01344720 ·Status: UNKNOWN ·Phase: PHASE4